article

increase

Anavex Life Sciences Corporation

wait

Seems crazy to me to unjust approvals that are going on while we wait on legitimate results!!!

But why wait 3 years with that when Anavex 50mg dose is likely better! !

So, if one waits months for an answer and then has to resubmit to another journal it can hold things up.

This is a shitshow till data is presented.

loss

but  losses  and  disappointment  with  Missling.

$AVXL Took my $250 loss and Got out guys too much noise not enough action.

but was faked by the move and held them to expiration and had to book a loss of $19,000.

shareholder

The krout has proven to be an a hole toward shareholders.

Missling is a greedy pig, doesnt see the bad he does by delaying intentionally, not only to shareholders,

i am telling for years that we need to fire that shitty guy just here to full his pockets without any consideration for his shareholders.

.this guy doesnt respect his shareholders and he must be sue for that.

$AVXL fire Missling, he has been here 9 years and done nothing to drive shareholder value other than BS hype

$AVXL why does the company not believe they are beholden to their shareholders?

$AVXL Unfortunately the Investorshub AVXL board has deteriorated to the point that it is basically a board consisting of almost entirely FUD with almost more bashers than true shareholders.

Messling is grossly deficient in anticipating the expectations of shareholders and the market.

$AVXL as corporate shareholder, I have sent an email on dec. 21st and a friendly reminder yesterday to IR - no response yet !!

One hand he says he care for shareholder value, on other hand he is purposely not sharing updates.

shareprice

$AVXL missling next time should change a few letters when hiring and SP will improve: from FDA to FBI former employee.

$AVXL Every time Missling speaks, the SP tanks…..amateurish communication, unbelievable.

It&#39;s stupid, it wastes time (and $$$) and it leaves the company vulnerable with a supressed SP.

Based on Rett alone, SP is well under 100$, sorry to bust your ballown,but please try to stay realist and keep a little credibility!

$AVXL The sp is wrong there must be a glitch

$AVXL not that i am happy with the SP overall

$AVXL Until you realize that and admit that the presenter screwed up in rushing the presentation the SP will stay where it’s at

$AVXL wandering when we will cross ANVS SP ;) 
never again!!!!

$AVXL we didnt cross ANVS SP yet, no good haha!

show

Take your money from this shit show and deposit in your bank account.

What an absolute unregulated criminal shit show this market has become.

Missling shows poor judgement and is not suited to be ceo.

SHOWS THE EXTREME WEAKNESS AND  DISTRESS THE STOCK IS UNDER.

but need more time to evaluate and announce a conference call for Monday instead we have a shit show.

$AVXL loving the seeking alpha article from yesterday

$AVXL yeah, great article from SA, instead of the 100&#39;s shitty ones.

Very good balanced article and settles with a recommendation on AVXL

$AVXL love how seeking alpha article was published just before the conference. .nincompoops.

It is absolutely fascinating reading all the commentary and articles on SA.

$AVXL New seeking alpha article is top notch.

Best of all, the data noted in the recent article were looking at changes over a 1-year period, so directly relevant to the AVXL trial.

An excellent article. https://www.sotcanalytics.com/special-edition-ctad-2022

$AVXL Great  article,  thanks to  Mayomobile!! https://www.sotcanalytics.com/special-edition-ctad-2022

As I mentioned, I wasn&#39;t expecting too much from this conference - seeing a 3% increase is great

$AVXL More excitement here than with $BIIB Approval and no big price increase.

First drug to show INCREASE in Cognition.

Very easy to calculate the huge  increase %, in the SP tomorrow.

We will only see a slight increase on great data.

We might reach 50% increase on Thursday to $13 or $14.

Increases in personnel is big bullish to me.

The upcoming stock increase will allow us to spread our money around in other good ways. 4.

business-result

Anavex&#39;s A2-73 Blarcamesine&#39;s trial results on 2 previously completed adult phase-3 trials were highly successful.

But the company actually has never seen before wonderful results.

If results hold up, the stock will achieve massive gains.

The results were excellent on the 2 completed adult trials, and because the 3rd trial is pediatric and early on the disease, they are expected to perform even better.

Alzheimer&#39;s is the most valuable and most difficult indication and most desired lately..  and only Anavex really has some great results with a great safety record. .

The  sava  results  trounce  you  guys  🤦🏻‍♂️🤦🏻‍♂️🤦🏻‍♂️😂😂😂

Sava has potential and the phase 3 results will show the truth.

drug

- Timo grimmer is in the team 
- All endpoints of the clinical trial were reached 
 
I firmly believe that the drug works and that the CEO has done a good job no matter how much he is criticized.

we have a drug, even many drugs, good for so many indications,  to become a giant pharma, we are about to get billions in revenues.

$AVXL The improvements in the drug arm cannot be lucky. .

I&#39;m looking forward to seeing the long term AD data on ANVS and have the feeling it&#39;s going to end up being the best in class AD treatment as well.

Do not listen to any FUD this drug is the real deal.

$AVXL amazing to see the actual benefits to people and their families of this “miracle drug” as they call it

$AVXL Dr. Perry said we have a legendary drug which actually reverses AD and is safe unlike Adulhelm.

trial

$AVXL amazing  avxl  still  in  singke  digits  after  a  supposedly  amazing  “pivotal”  trial  readout  🤦🏻‍♂️🤦🏻‍♂️🤦🏻‍♂️😂😂😂

$AVXL The trial met both co-primary and secondary endpoints showing statistically significant reduction of clinical decline as measured by those endpoints.

$AVXL Australia trial data meets the gold standard.

2-73 has orphan designation for Rett which combined with the multiple Rett trials and it very good safety record should make it a great candidate for AA.

This company has yet to fail to meet endpoints on any trial and the thousands of papers on the MOA  eliminates fraud with science, and the company is in great fiscal shape so no shenanigans there.

Nuwellis Inc

company

$NUWE 
this company is worth more than $4 million
current market cap is a joke

Our predictive algorithm judges the stock price of this company will fall sharply in the short-term and, in the long run, faces severe disadvantages $NUWE

The trained model judges that this company s stock price clearly has a bad short-term setup also clearly lacks long-term fundamentals $NUWE

Incompetence of this company is shocking!

$NUWE how this company is trading at this level is just BEYOND absurd.

fund

$NUWE just insane these funds can turn on computers and just short infinite shares, just unbelievable how rigged the market is

$NUWE Jesus these funds are mad man they are shorting hard

holder

bear

$NUWE bhaha the trolls here are worse than any other board wtf

Even repeat same shut word by word, daily

$CREG $NUWE $XELA $BTC.X my character is being called out by a troll @Invartis proof hurts this is my track record

$NUWE wow this morning bears PT of 7-7.50 for the day didnt aged well

$NUWE why does st allow these dumb trolls! ?

bears are here to scare you cause they shorted at under 11 .

$NUWE another bear trap, they don&#39;t want you to make money

Problem - that company is small cap and very easy to manipulate.

Bullish article yesterday!📈

$TRKA Keeping watch for re-entry.

Brilliant And hilarious  article. linked.

$NUWE it’s a 42% increase from the previous 4th quarter earnings

$RSLS $NUWE $PIXY $DBGI and RSLS is primed again  nice volume today and we all know volume precedes price increase   could see something big in AH or PM

#1 trending 🚀🚀🚀

Preliminary unaudited revenue for the fourth quarter and full year 2022 is anticipated to be approximately $2.3 million and $8.5 million, respectively, representing an increase of 42% and 8% over the same periods last year.

The small increase is barely visible and therefore very high potential.

From the start of the first increase in volume til now the price has not dipped below 10.

From the start of the first increase to now the price has not dipped below.

price

Recent price changes and earnings estimate revisions indicate this would be a good stock for momentum investors with a Momentum Score of B.

$NUWE atleast the offering is at a somewhat reasonable price and not 25% below market..

$NUWE Strong Buy    
Target Price    
$500    
6,181.4% Upside   
https://public.com/stocks/nuwe

$NUWE  Strong Buy   
Target Price   
$500   
6,181.4% Upside  
https://public.com/stocks/nuwe

$NUWE Strong Buy  
Target Price  
$500  
6,181.4% Upside  
https://public.com/stocks/nuwe

$NUWE Strong Buy 
Target Price 
$500 
6,181.4% Upside 
 
 https://public.com/stocks/nuwe?symbol=nuwe

Ai sector is hot and we price is atl territory, about to go up from here🚀 
 
$PSNL $BBAI $RSLS $NUWE $GNS

I bought every dip here in germany, prices under 10 are real gifts!

$NUWE the fact the price is not under 8 yet is good!!

volume

$NUWE loads of shares changing Hands Bulls taking over💪🚀💪🚀

Massive bullish volume

$NUWE good volume today buyers approaching with interest

Volume brings big fat juicy fucking gains!

$NUWE 22000 volume and they drop it 4% 🤔🤔🤔🤣🤣🤣🤣🤣🤣

start

🚀  
  
The 0.75 mark signals a strong start, Get set for an parabolic breakthrogh of limitless🔥🚀  
  
Time to BANK boys💰

$NRBO $NUWE $OBLG $QNRX 
Definitely a nice start with NRBO!

Seems like people starts to find the hidden gem $RCRT 💎could be the next big Ai-Runner!

Aurinia Pharmaceuticals Inc

$AUPH ladies, gentlemen and everything in between or neither, this is what you call a bear trap

$AUPH smells like a bear trap like yesterday.

Not Achieved - Protect the companies intellectual property and do not put it at risk with a patent troll lawsuit for pennies.

$AUPH Neil and Robert could not have been to happy with Peter and his patent troll antics.

hold

$AUPH ZURA is up +300% and this shit cant even hold $9

I can&#39;t believe the lack of communication from this team. Hold the carrot out in front (partnership, spokeperson, stockholder value.  )

Seriously, what is his excuse this year to hold a meeting where there is no opposition voices?

They never hold gains especially this one with its history and management team

Stock price is like drunk person, cant hold any gains, always falling

Almost 2 years of wasted time no matter how long they’ll hold onto patent.

life

They could take your identity and mess your life up.

That’s how they live their lavish life at the expense of retails.

Expect a total non-sense of options gift for a gang of crooked m***f*** lazy asses that only burnt 2 years of our lives with mistaken strategies and very poor choices.

Wrong for your whole life and all your calls.

You are evil and continue to kill so many lives because you could not and will not be able to ramp up sales better than BP.

$AUPH 

This SOB CeO made everyone’s life a living hell.

To be honest I have never seen in my entire life  a company with such troubles who does not communicate and also a CEO who is not defending its SP.

It’s mind boggling how this is allowed to continue, especially with a patent life now at risk of being severely crippled.

- Lupkynis Price +8 % in Dec 
- Erol is Magnificent 
 
Bad: 
- Sell the fucking Company!

$AUPH Producer price index is in and not looking good.

$AUPH WTF is going on here, why all the push for good news and share price made a small move up and now it’s going to be all given back, illegal options granting, at least it should be is that why we are dropping

$AUPH poor management, proven price manipulation, sell all before the final collapse

Regardless of whatever you discuss, the price is halted.

sale

barely any advertising, terrible sales, no direction, no hunger, no work ethic.

$AUPH Unhappy with 
-&gt; 50%+ dilution in last 36 m.
-&gt; Poor performances in sales and market penetration, absurd bonuses paid to management…
-&gt; Misleading statements, promises from mgmt whom does not deliver… 

You know what to do @ 23 AGM!

This crap won&#39;t change until new leadership is in place or better ending like sale of the company.

The only thing left to do is whine and complain about sales, management, and lack of a buyout.

Greenleaf doesn’t have the experience or knowledge to make sales grow.

NOT growing sales for 3 quarters and losing money at a faster rate is not the path of a successful company.

$AUPH what the hell is wrong with this company, CEO can’t get the ball rolling, either sell the company or put in some real effort trying to advertise Lupkynis, to boost sales.

The value of the asset in PGs hands shrinks month by month as their sales numbers stink up the room.

$AUPH 
It can&#39;t get any better, an indepth/informative article and a shareholders platform!

Thanks for the article from Dr. K. 
Nice to see somebody at AUPH is getting the message out there.

$AUPH wow - the SA article today by Avisol Capital Partners🥸🤡

:-) btw interesting steep increase in 22 Q2.

Sales improving, patent safe, patent extension 2037, increase in insurance covering.

Once again the shorts gained .01 cent with an increase of 14.9% over January.

I think it’s just consistent script number increase WoW/MoM.

This is an increase of greater than 75% versus 2021 and an improvement of approximately 13% over Q3.

• 97% gross margin (sheesh)
• Excited bout new 
partnership(details soon)
• drug price increase 
• 85% conversion psf&#39;s (stellar)
• Tam is there, huge growth opportunity if they can get more sle patients tested, 75% would capture many.

$AUPH Institutional position increase in the past few weeks = bullish.

news

$AUPH Good news for investors  Options Flow 🤖 analysis shows upward momentum.

I guarantee if the company announced a new CEO, SP instantly rises 20% on the news alone…

$AUPH  Great news would be partnering with BMY, GSK etc… not waiting this inept CEO to tell you someone is going to help him out with marketing.

$AUPH  I believe we will see some positive news this week.

$AUPH looks like we hv triple good news.. 
1.SVB out of the way
2.

Usually good news for auph comes at a time when the market shits the bed.

With heavy intel networks, tutes or a group of individuals taking this up north, expecting some major positive news.

$AUPH I have listed 9 catalysts, which gives me confidence its share price will move higher.

Peter and BoDs got RSU recently and they want to stock price to go 🆙 ⬆️

The price in low and has lots of potential. So.

$AUPH 10 looks pretty even if it is the AH price.

are actually buys, since they are the same price as 2 minutes before

Share price is above all simple and exponential moving averages from 10d to 200d too.

$AUPH Nice price action on lower then 10 day volume average.

.very interesting spikes in the stock price

Its actually positive that &quot;they&quot; r not letting the price drop precipitously.

longs

Next few hours should be interesting for us longs as that just may happen here.

Meanwhile I will be enjoying the dance videos til it happens. GL to all longs and shorts :-)

$AUPH things are looking up for us longs here again!

Things are going to improve for hardheaded AUPH longs.

$AUPH Have a nice Thanksgiving everyone, things are going to get better for all of us longs.

$AUPH how can you not feel awful for longs here.

Hang in there longs because this one has the potential for huge ROI long term.

AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Jan, 31, 2023

Jan, 30, 2023

NUWE

Nuwellis Inc

-48.27%

$9.24 - $4.78

Mar, 18, 2023

Feb, 3, 2023

Divihomes is Now Live

AUPH

Aurinia Pharmaceuticals Inc

3.07%

$8.48 - $8.74

Mar, 22, 2023

Dec, 8, 2022

AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Jan, 31, 2023

Jan, 30, 2023

Jan, 18, 2023

Jan, 12, 2023

Jan, 6, 2023

Dec, 31, 2022

Dec, 21, 2022

Dec, 13, 2022

Dec, 7, 2022

Dec, 7, 2022

NUWE

Nuwellis Inc

-48.27%

$9.24 - $4.78

Mar, 18, 2023

Feb, 3, 2023

AUPH

Aurinia Pharmaceuticals Inc

3.07%

$8.48 - $8.74

Mar, 22, 2023

Dec, 8, 2022

Nov, 6, 2022